Related references
Note: Only part of the references are listed.Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
Florence C. Guibal et al.
BLOOD (2009)
PML-RARα initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors
S. Wojiski et al.
LEUKEMIA (2009)
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy:: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
Miguel A. Sanz et al.
BLOOD (2008)
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells
Ellen Weisberg et al.
BLOOD (2008)
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data
Duane C. Hassane et al.
BLOOD (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Modeling of C/EBP alpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells
Peggy Kirstetter et al.
CANCER CELL (2008)
The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells
Irene M. Min et al.
CELL STEM CELL (2008)
Group VI phospholipases A2:: Homeostatic Phospholipases with significant potential as targets for novel therapeutics
W. P. Wilkins et al.
CURRENT DRUG TARGETS (2008)
Retinoic acid receptors, hematopoiesis and leukemogenesis
Steven J. Collins
CURRENT OPINION IN HEMATOLOGY (2008)
Calcium-independent phospholipase A2 mediates proliferation of human promonocytic U937 cells
Maria A. Balboa et al.
FEBS JOURNAL (2008)
Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells
Beata Pajak et al.
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA (2008)
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
Michael G. Kharas et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
S. Park et al.
LEUKEMIA (2008)
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
L. S. Steelman et al.
LEUKEMIA (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Asap: A Framework for Over-Representation Statistics for Transcription Factor Binding Sites
Troels T. Marstrand et al.
PLOS ONE (2008)
JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update
Jan Christian Bryne et al.
NUCLEIC ACIDS RESEARCH (2008)
Phospholipase A2 as targets for anti-cancer drugs
Brian S. Cummings
BIOCHEMICAL PHARMACOLOGY (2007)
Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism
Rasha Hammamieh et al.
BMC CANCER (2007)
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy:: The Japan Adult Leukemia Study Group (JALSG) APL97 study
Norio Asou et al.
BLOOD (2007)
CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia
Naoki Hosen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Role of the polycomb repressive complex 2 in acute promyelocytic leukemia
Raffaella Villa et al.
CANCER CELL (2007)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)
The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
Justin Lamb et al.
SCIENCE (2006)
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
Leming Shi et al.
NATURE BIOTECHNOLOGY (2006)
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V. Krivtsov et al.
NATURE (2006)
Gene expression changes associated with progression and response in chronic myeloid leukemia
JP Radich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene selection and classification of microarray data using random forest -: art. no. 3
R Díaz-Uriarte et al.
BMC BIOINFORMATICS (2006)
Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations
F. G. Ruecker et al.
LEUKEMIA (2006)
TRANSFAC (R) and its module TRANSCompel (R): transcriptional gene regulation in eukaryotes
V. Matys et al.
NUCLEIC ACIDS RESEARCH (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Functional analysis of human hematopoietic stem cell gene expression using zebrafish
CE Eckfeldt et al.
PLOS BIOLOGY (2005)
Gene expression profile reveals deregulation of genes with relevant functions in the different subclasses of acute myeloid leukemia
NC Gutéerrez et al.
LEUKEMIA (2005)
The transcriptional program of terminal granulocytic differentiation
K Theilgaard-Mönch et al.
BLOOD (2005)
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
A Nebbioso et al.
NATURE MEDICINE (2005)
Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway
A Insinga et al.
NATURE MEDICINE (2005)
PML-RARA-RXR oligomers mediate retinoid and rexinoid/cAMP cross-talk in acute promyelocytic leukemia cell differentiation
D Kamashev et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
L Bullinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Gene expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation
K Stegmaier et al.
NATURE GENETICS (2004)
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα.
P Zhang et al.
IMMUNITY (2004)
A model-based background adjustment for oligonucleotide expression arrays
ZJ Wu et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
Oncogenic action of secreted phospholipase A2 in prostate cancer
P Sved et al.
CANCER RESEARCH (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
ExPASy: the proteomics server for in-depth protein knowledge and analysis
E Gasteiger et al.
NUCLEIC ACIDS RESEARCH (2003)
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
MJ Keating et al.
BLOOD (2002)
E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo
BT Porse et al.
CELL (2001)
The t(1,12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion
F Salomon-Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers
RJ Lin et al.
MOLECULAR CELL (2000)
Share Paper
